Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre J Issa

Showing results (101-110 of 204) with videos related to

Pageof 21
Sort By:
Gastroenterology|July 14, 2005
The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancerKimishige Akino, Minoru Toyota, Hiromu Suzuki, et al.
Plos Genetics|October 31, 2007
Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promotersLanlan Shen, Yutaka Kondo, Yi Guo, et al.
Cancer Research|January 6, 2012
DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memoryNoël J-M Raynal, Jiali Si, Rodolphe F Taby, et al.
Clinical Epigenetics|January 3, 2024
MC180295 is a highly potent and selective CDK9 inhibitor with preclinical in vitro and in vivo efficacy in cancerHanghang Zhang, Chen Huang, John Gordon, et al.
Plos Genetics|August 30, 2008
An Sp1/Sp3 binding polymorphism confers methylation protectionYanis A Boumber, Yutaka Kondo, Xuqi Chen, et al.
Cancer Research|March 3, 2007
RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosisYanis A Boumber, Yutaka Kondo, Xuqi Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 8, 2007
Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)In-Seon Choi, Marcos R H Estecio, Yasuhiko Nagano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2011
Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patientsThushangi N Pathiraja, Priya B Shetty, Jaroslav Jelinek, et al.
Epigenetics|December 27, 2022
Non-pathogenic microbiota accelerate age-related CpG Island methylation in colonic mucosaAng Sun, Pyounghwa Park, Lauren Cole, et al.
Blood|February 15, 2003
Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemiaLanLan Shen, Minoru Toyota, Yutaka Kondo, et al.
Pageof 21

Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
Gastroenterology|July 14, 2005
The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancerKimishige Akino, Minoru Toyota, Hiromu Suzuki, et al.
Plos Genetics|October 31, 2007
Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promotersLanlan Shen, Yutaka Kondo, Yi Guo, et al.
Cancer Research|January 6, 2012
DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memoryNoël J-M Raynal, Jiali Si, Rodolphe F Taby, et al.
Clinical Epigenetics|January 3, 2024
MC180295 is a highly potent and selective CDK9 inhibitor with preclinical in vitro and in vivo efficacy in cancerHanghang Zhang, Chen Huang, John Gordon, et al.
Plos Genetics|August 30, 2008
An Sp1/Sp3 binding polymorphism confers methylation protectionYanis A Boumber, Yutaka Kondo, Xuqi Chen, et al.
Cancer Research|March 3, 2007
RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosisYanis A Boumber, Yutaka Kondo, Xuqi Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 8, 2007
Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)In-Seon Choi, Marcos R H Estecio, Yasuhiko Nagano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2011
Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patientsThushangi N Pathiraja, Priya B Shetty, Jaroslav Jelinek, et al.
Epigenetics|December 27, 2022
Non-pathogenic microbiota accelerate age-related CpG Island methylation in colonic mucosaAng Sun, Pyounghwa Park, Lauren Cole, et al.
Blood|February 15, 2003
Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemiaLanLan Shen, Minoru Toyota, Yutaka Kondo, et al.
Pageof 21